Banque Cantonale Vaudoise Exelixis, Inc. Transaction History

Banque Cantonale Vaudoise

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$20.34 - $23.73 $129,260 - $150,804	-6,355 Reduced 84.12%	1,200 $27,000
Q1 2024 Apr 10, 2024	BUY	$20.17 - $23.93 $15,752 - $18,689	781 Added 11.53%	7,555 $179,000
Q4 2023 Feb 07, 2024	BUY	$19.25 - $24.13 $46,546 - $58,346	2,418 Added 55.51%	6,774 $163,000
Q2 2023 Aug 09, 2023	SELL	$18.17 - $20.48 $10,902 - $12,288	-600 Reduced 12.11%	4,356 $83,000
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $5,460 - $6,347	-365 Reduced 6.86%	4,956 $79,000
Q3 2022 Oct 17, 2022	BUY	$15.68 - $22.27 $3,857 - $5,478	246 Added 4.85%	5,321 $84,000
Q2 2022 Aug 02, 2022	SELL	$17.44 - $23.16 $14,143 - $18,782	-811 Reduced 13.78%	5,075 $106,000
Q1 2022 May 09, 2022	SELL	$17.03 - $22.67 $59,315 - $78,959	-3,483 Reduced 37.18%	5,886 $133,000
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $6,320 - $8,730	-399 Reduced 4.08%	9,369 $171,000
Q3 2021 Oct 29, 2021	SELL	$16.3 - $21.14 $3,145 - $4,080	-193 Reduced 1.94%	9,768 $206,000
Q1 2021 May 11, 2021	BUY	$20.53 - $25.22 $56,026 - $68,825	2,729 Added 37.74%	9,961 $225,000
Q4 2020 Feb 05, 2021	SELL	$18.39 - $24.8 $2,648 - $3,571	-144 Reduced 1.95%	7,232 $145,000
Q3 2020 Oct 30, 2020	BUY	$20.67 - $26.94 $9,198 - $11,988	445 Added 6.42%	7,376 $180,000
Q2 2020 Jul 22, 2020	BUY	$16.46 - $27.42 $114,084 - $190,048	6,931 New	6,931 $165,000

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.